Myriad Genetics, Inc.
MYGN
$10.18
-$0.34-3.23%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -1.27% | 0.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.27% | 0.85% | |||
| Cost of Revenue | -5.98% | -1.40% | |||
| Gross Profit | 0.73% | 1.84% | |||
| SG&A Expenses | -2.23% | -4.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.38% | -2.24% | |||
| Operating Income | 2.81% | 28.51% | |||
| Income Before Tax | -84.43% | 43.01% | |||
| Income Tax Expenses | 277.78% | 280.00% | |||
| Earnings from Continuing Operations | -92.31% | 39.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -92.31% | 39.78% | |||
| EBIT | 2.81% | 28.51% | |||
| EBITDA | -13.64% | 77.55% | |||
| EPS Basic | -91.90% | 39.99% | |||
| Normalized Basic EPS | 8.58% | 26.05% | |||
| EPS Diluted | -92.72% | 40.71% | |||
| Normalized Diluted EPS | 8.58% | 26.05% | |||
| Average Basic Shares Outstanding | 0.22% | 0.33% | |||
| Average Diluted Shares Outstanding | 0.22% | 0.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
